Cancer World Magazine
  • About the Journal
    • Editorial Team
    • Leadership and Management
    • Journal staff
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnership
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
NEWSLETTER  |  PRINT VERSION
Facebook
Twitter
LinkedIn
Cancer World Magazine
Cancer World Magazine
  • About the Journal
    • Editorial Team
    • Leadership and Management
    • Journal staff
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnership
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
Cancer World Magazine > Voices > EORTC pushes for the State of Science in Care
  • Voices

EORTC pushes for the State of Science in Care

  • 30 May 2020
  • Denis Lacombe
Total
0
Shares
0
0
0
0
0

Covid-19 has taught us that we need to think differently about many issues. One of the most important, in my view, is that we need to be ready to act quickly and decisively rather than just identifying and talking about potential problems.

In the oncology field, we have been discussing the importance of the role of independent cancer research in Europe for some time. Several reports have shown a need for change, both in the perception and practice of such research, and in the communication of the current problems to policymakers and others.  Many researchers now agree that research until now has been too drug-centred and insufficiently patient-based. How we can take practical measures to change this has been a concern of EORTC for a while.

At the beginning of April, EORTC contacted ECCO to set up a conference call between representatives of 15 of its member societies to discuss how to take forward the proposals contained in the EORTC Manifesto, presented to the European Parliament in 2019. All those taking part supported further action based around the three scientific pillars of clinical research, epidemiology, and health economics. Taken together, these three pillars can identify gaps in research, and the treatments – drugs, surgery, combination therapies etc. – that should be optimised to best cater to the needs of patients and of public health.

The response of the European Parliament’s Panel for the Future of Science and Technology (STOA) to the growing demand for patient-centric research has been encouraging. They launched a research project to explore views on drug development trials specifically related to treatment optimisation. The comprehensive report on the subject is now available on the STOA website , and suggests new approaches to ensure that treatment optimisation studies are properly integrated into drug development studies and taken into account when regulators, payers and clinicians take decisions. However, significant political effort will be required to achieve this, since both European and national legislative frameworks will need to be modified.

EORTC, supported by ECCO, will be pushing for an independent, patient-centred societal approach to decision-making in healthcare systems. We will name this new approach ‘the State of Science in Care.’ It will build on two principles:

  • The identification of candidate therapies and the assessment of key clinical questions to be taken forward in healthcare systems based on a multinational, independently driven, conditional access system, and
  • The development of therapeutic strategies based on a scientific rationale that is beyond the remit of commercial pipelines.

Based on the three scientific pillars mentioned above, epidemiological and clinical researchers will collaborate to make sure that societal and clinical needs are met, while health economists will look at the efficiency and value of the potential treatments. The objective of the State of Science will be to conduct independent optimisation studies to identify the best way of using the selected treatments in healthcare systems.

Although the project already has substantial support, bringing it to fruition will need considerable effort, together with maximum collaboration between scientific organisations, patient representatives, and health economists, as well as the support of policymakers. The backing of European cancer societies is a sign that we are on the right track, but now we need to be seen to be acting rather than continuing to comment. There is an English expression: « Fine words butter no parsnips » that sums up the situation nicely. I am looking forward to working closely with all those who want to make the State of Science in Care become a reality rather than a slogan.

 

ECCO speaks out in support

“The EORTC Treatment Optimisation manifesto has struck a chord with the membership of the European Cancer Organisation, offering as it does a chance to redraw the paradigm for research and investment in cancer, said Dr Matti Aapro, ECCO president. “ECCO’s new Health Systems and Treatment Optimisation network, chaired by Yolande Lievens and Denis Lacombe, aims to add to the momentum for change and make this agenda unstoppable.”

Download Pdf
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Related Topics
  • delivery of care
  • ECCO
  • EORTC
Denis Lacombe

EORTC Director General

Previous Article
  • News

A global registry for children with cancer and COVID-19

  • 25 May 2020
  • Alessia De Chiara
View Post
Next Article
  • News

Cancer drugs, costs and clinical benefits are not aligned

  • 1 June 2020
  • Elena Riboldi
View Post
You May Also Like
View Post
  • Patient’s Voices
  • Voices

From the New Yorker: What Cancer Takes Away

  • Anne Boyer
  • 22 January 2021
View Post
  • Voices

A 360° approach to a 360° problem: why a mission is the right approach to solving cancer

  • Bettina Ryll
  • 2 December 2020
View Post
  • Voices

Workload doubled, resources halved: cancer patient groups need help to survive the pandemic

  • Clara MacKay
  • 31 July 2020
View Post
  • Voices

COVID-19 is delaying diagnosis, but getting back to normal is not what we need

  • Zorana Maravic
  • 24 June 2020
View Post
  • Voices

Telling stories about cancer ‒ six award-winning journalists show how it’s done

  • Simon Crompton
  • 9 June 2020
View Post
  • Voices

Cancer nursing, COVID-19 and healthcare inequality

  • Andreas Charalambous
  • 18 May 2020
View Post
  • Voices

Delivering cancer care during the pandemic in Europe’s most overstretched health system

  • Geta Roman
  • 10 May 2020
View Post
  • Voices

COVID – are cancer patients being protected?

  • yAntonio
  • 18 March 2020

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

search
or search in Cancer World archive
Latest news
  • Coffee may protect against prostate cancer
    • 20 January 2021
  • Financial burden on older adults with advanced cancer worsens quality of life
    • 15 January 2021
  • Integrated imaging opens the way for virtual biopsies
    • 15 January 2021
  • Cancer survivors at greater risk of subsequent primary cancers
    • 30 December 2020
  • Immunotherapy cardiotoxicity higher than previously estimated
    • 24 December 2020
Latest printed issue
Article
  • Berlin pilot project brings precision care to the peripheries
    • 15 January 2021
  • Highlights of 2020 American Society of Hematology (ASH) meeting
    • 14 January 2021
  • Highlights of 2020 San Antonio Breast Cancer Symposium
    • 28 December 2020
Newsletter

Don't miss our newsletter

Would you like to receive our bimonthly e-newsletter with the latest news from Cancer World magazine?

Subscribe now
Social

Would you follow us ?

Contents
  • Prof Gordon McVie 1945 – 2021
    • 22 January 2021
  • From the New Yorker: What Cancer Takes Away
    • 22 January 2021
  • Interview to Christian Rolfo
    Liquid biopsy for early stage lung cancer moves closer
    • 12 January 2021
MENU
  • About the Journal
    • Editorial Team
    • Leadership and Management
    • Journal staff
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnership
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
Cancer World Magazine
  • About the Journal
  • Articles
  • Media Corner
  • Privacy Policy
  • Cookie Policy
Archivio Cancerworld

Input your search keywords and press Enter.